Clinical Trial

TCRM for Correction of Cheek Including Fine Lines

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 8, 2025 (before its estimated September 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this clinical study is to evaluate benefits and risks of injecting TCRM in the cheek including fine lines. The goal is to show that treatment with TCRM will result in correcting the cheek area including the fine lines at 4 weeks after last treatment (initial injection or touch up) on subjects.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-08-27.
Trial Details
NCT Number NCT07145905
Lead Sponsor Teoxane SA
Conditions Skin Aging, Cheek Wrinkles
Enrollment 130 participants
Start Date 2023-11-30
Primary Completion 2025-09-30 (estimated)
Study Completion 2026-01-31 (estimated)
Updated on ClinicalTrials.gov 2025-09-08